Publication | Closed Access

Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon α-2b and ribavirin

Vitamin EHepatic DisordersHepatologyViral HepatitisLiver PhysiologyMedicineImmunologyAntiviral TherapyHepatitisEicosapentaenoic AcidHepatotoxicityCombination TherapyLiver DiseasePharmacology